Wl. Holman et al., TISSUE OXYGENATION WITH GRADED DISSOLVED-OXYGEN DELIVERY DURING CARDIOPULMONARY BYPASS, Journal of thoracic and cardiovascular surgery, 110(3), 1995, pp. 774-785
Background: Intravascular perfluorochemical emulsions together with a
high oxygen tension may increase the delivery of dissolved oxygen to u
seful levels, The hypothesis of this study is that increasing the diss
olved oxygen content of blood with incremental doses of a perfluoroche
mical emulsion improves tissue oxygenation during cardiopulmonary bypa
ss in a dose-related fashion, Methods and Results: Oxygen utilization
was studied in a profoundly anemic canine model of hypothermic cardiop
ulmonary bypass, Forty-two dogs underwent normovolemic hemodilution to
a hematocrit of 15.8% +/- 0.6% (mean +/- standard error of the mean),
Cardiopulmonary bypass was begun and resulted in a hematocrit of 9.4%
+/- 0.6%. A standard priming solution was used in the control group (
n = 12), and the test groups received 1.35 gm perfluorochemical . kg(-
1) (n = 10 dogs), 2.7 gm perfluorochemical . kg(-1) (n = 10 dogs), or
5.4 gm perfluorochemical . kg(-1) (n = 10 dogs) through the venous ret
urn cannula, Each animal underwent a series of randomized pump flows (
0.25, 0.5, 1.0, 1.5, 2.0, and 3.0 L . min(-1). m(-2)) at 32 degrees C,
After the randomized flows were completed at 32 degrees C, the temper
ature was raised to 38 degrees C and cardiopulmonary bypass was discon
tinued, Mortality from cardiac failure on separation from cardiopulmon
ary bypass was 42% in the control group and 20% in perfluorochemical-t
reated groups. The mean perfluorochemical dose was higher in survivors
than in nonsurvivors (2.9 +/- 0.4 versus 1.3 +/- 0.5 gm perfluorochem
ical . kg(-1); p < 0.05), No differences in oxygen consumption or tran
sbody lactate gradient were found between groups during cardiopulmonar
y bypass, Analysis of mixed venous oxygen tension (a surrogate measure
for tissue oxygenation) as a function of cardiopulmonary bypass flow
normalized to body surface area showed that the control group had sign
ificantly lower mixed venous oxygen tension (p < 0.05) than the perflu
orochemical emulsion-treated groups, Furthermore, the differences were
related to the perfluorochemical emulsion dose, These differences in
mixed venous oxygen tension continued after termination of cardiopulmo
nary bypass, The coronary sinus oxygen tension and cardiac arterial-ve
nous oxygen content differences during and after cardiopulmonary bypas
s were similar among the control and perfluorochemical emulsion-treate
d animals, Dissolved oxygen consumption during and after cardiopulmona
ry bypass was calculated, Dissolved oxygen consumption increased in th
e perfluorochemical-treated animals in a perfluorochemical dose-relate
d manner and was significantly higher in perfluoro-chemical-treated an
imals than in the control animals (p < 0.05). Conclusions: Graded incr
eases in mixed venous oxygen tension during cardiopulmonary bypass wer
e observed in response to graded increases in the dissolved oxygen del
ivery. These data suggest that enhancing oxygenation with perfluoroche
mical-dissolved oxygen is an effective temporary substitute for the us
e of hemoglobin-bound oxygen during cardiopulmonary bypass. Perfluoroc
hemical-dissolved oxygen may be particularly beneficial in the setting
of multiple hypoxic stresses.